Erbitux slightly boosts survival in cancer study

June 1st, 2008 in Medicine & Health / Cancer

(AP) -- Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found.

---

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

---